Details for Patent: 10,751,333
✉ Email this page to a colleague
Which drugs does patent 10,751,333 protect, and when does it expire?
Patent 10,751,333 protects KONVOMEP and is included in one NDA.
This patent has five patent family members in five countries.
Drugs Protected by US Patent 10,751,333
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | KONVOMEP | omeprazole; sodium bicarbonate | FOR SUSPENSION;ORAL | 213593-001 | Aug 30, 2022 | RX | Yes | Yes | 10,751,333 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,751,333
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3147586 | ⤷ Subscribe | |||
| China | 114761002 | ⤷ Subscribe | |||
| European Patent Office | 3999066 | ⤷ Subscribe | |||
| Mexico | 2022000623 | ⤷ Subscribe | |||
| World Intellectual Property Organization (WIPO) | 2021011669 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
